Literature DB >> 15663341

Topical therapy for fungal infections.

Amber A Kyle1, Mark V Dahl.   

Abstract

Fungi often infect the skin surface and subsequently invade the stratum corneum to avoid being shed from the skin surface by desquamation. Pharmacologic agents applied to the surface of the skin in the form of creams, lotions, or sprays, readily penetrate into the stratum corneum to kill the fungi (fungicidal agents), or at least render them unable to grow or divide (fungistatic agents). Thus, topical therapies work well to rid the skin of topical fungi and yeasts. Azole drugs such as miconazole, clotrimazole, and ketoconazole are fungistatic, limiting fungal growth but depending on epidermal turnover to shed the still-living fungus from the skin surface. Allylamines and benzylamines such as terbinafine, naftifine, and butenafine are fungicidal, actually killing the fungal organisms. Fungicidal drugs are often preferred over fungistatic drugs for treatment of dermatophytic fungal infections, since treatment times as short as one application daily for 1 week are associated with high cure rates. Furthermore, patients often stop treatments when the skin appears healed, usually after about a week of treatment. If this short-term treatment is stopped, fungi recur more often when fungistatic, rather than fungicidal, drugs have been used. Yeast infections such as those caused by Candida albicans respond less well to allylamine drugs. The azole drugs are often preferred for these types of infections. Nail infections are difficult to cure with topical therapies because the infections usually occur under the nail instead of on top of it and products penetrate poorly, if at all, through the nail plate. Infections of hair follicles, nails, and widespread infections often require systemic treatments. Antifungal agents are compounded into many different types of vehicles. Patients often prefer to treat weeping infections with spray formulations. Most physicians prescribe branded products in cream or lotion bases. Cost is a factor dictating prescription choice, especially since most products work well regardless of mechanism of action. Cost becomes especially important when infections involve large areas of the body surface. This article reviews various treatments of cutaneous fungal infections, with special emphasis on cure rates and rationales for choosing particular products.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15663341     DOI: 10.2165/00128071-200405060-00009

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  16 in total

Review 1.  Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.

Authors:  Sam G Raney; Thomas J Franz; Paul A Lehman; Robert Lionberger; Mei-Ling Chen
Journal:  Clin Pharmacokinet       Date:  2015-11       Impact factor: 6.447

2.  Identification of Miscellaneous Peptides from the Skin Secretion of the European Edible Frog, Pelophylax kl. Esculentus.

Authors:  Xiaole Chen; He Wang; Lei Wang; Mei Zhou; Tianbao Chen; Chris Shaw
Journal:  Protein J       Date:  2016-08       Impact factor: 2.371

3.  Novel and convenient synthesis of 1-(pyridinylmethyl)-2-naphthols and 1-(pyridinylmethylene)-2-tetralones from 2-tetralones.

Authors:  Po-Jung J Huang; Elizabeth Potter; Amitabh Jha
Journal:  Mol Divers       Date:  2009-08-07       Impact factor: 2.943

4.  Comparison of topical anti- fungal agents sertaconazole and clotrimazole in the treatment of tinea corporis-an observational study.

Authors:  Raghu Prasada Malladar Shivamurthy; Shashikala Gowdara Hanumantappa Reddy; Ravindra Kallappa; Shankar Achar Somashekar; Deepa Patil; Umakant N Patil
Journal:  J Clin Diagn Res       Date:  2014-09-20

5.  In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery.

Authors:  Mohhammad Ramzan; Samuel Gourion-Arsiquaud; Afzal Hussain; Jaspreet Singh Gulati; Qihong Zhang; Sonia Trehan; Vinam Puri; Bozena Michniak-Kohn; Indu Pal Kaur
Journal:  Drug Deliv Transl Res       Date:  2022-01-07       Impact factor: 4.617

Review 6.  Fungal keratitis: Mechanisms of infection and management strategies.

Authors:  Christopher Donovan; Eduardo Arenas; Ramesh S Ayyala; Curtis E Margo; Edgar M Espana
Journal:  Surv Ophthalmol       Date:  2021-08-20       Impact factor: 6.197

Review 7.  Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.

Authors:  Jamie D Croxtall; Greg L Plosker
Journal:  Drugs       Date:  2009       Impact factor: 9.546

8.  Antifungal activity of extracts from Piper aduncum leaves prepared by different solvents and extraction techniques against dermatophytes Trichophyton rubrum and Trichophyton interdigitale.

Authors:  Maximillan Leite Santos; Chaiana Froés Magalhães; Marcelo Barcellos da Rosa; Daniel de Assis Santos; Beatriz Gonçalves Brasileiro; Leandro Machado de Carvalho; Marcelo Barreto da Silva; Carlos Leomar Zani; Ezequias Pessoa de Siqueira; Rodrigo Loreto Peres; Anderson Assunção Andrade
Journal:  Braz J Microbiol       Date:  2014-03-10       Impact factor: 2.476

9.  Novel lecithin-integrated liquid crystalline nanogels for enhanced cutaneous targeting of terconazole: development, in vitro and in vivo studies.

Authors:  Yosra Sr Elnaggar; Sara M Talaat; Mohammed Bahey-El-Din; Ossama Y Abdallah
Journal:  Int J Nanomedicine       Date:  2016-10-25

10.  Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine cream (1%) versus luliconazole (1%) cream in patients with dermatophytoses: a pilot study.

Authors:  Hr Jerajani; C Janaki; Sharath Kumar; Meghana Phiske
Journal:  Indian J Dermatol       Date:  2013-01       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.